Cartabuke: The biggest challenges in the treatment of Crohn’s disease include managing refractory disease, preventing and treating complications, and addressing the high cost of biologic therapies.

For moderate to severe Crohn's disease, the combination of infliximab plus azathioprine appears to produce higher rates of clinical remission than either agent alone.

Specific protein signatures could predict a future diagnosis of Crohn disease and ulcerative colitis, potentially enabling earlier intervention and improving patient outcomes.

Scientists have discovered a link between bacteria in the mouth and gut and the progression of cognitive decline in Parkinson's disease. Specific changes in these bacteria, known as the microbiome ...

Hundreds of participants gathered at Sawyer Point and Yeatman's Cove for the Crohn's and Colitis Foundation's largest fundraising event.

A study led by biomedical scientists at the University of California, Riverside School of Medicine shows how a genetic mutation associated with Crohn’s disease can worsen iron deficiency and ...

Discover 8 foods that calm Crohn's symptoms and 6 to avoid. Learn which fruits, proteins, and grains work best for managing inflammatory bowel disease.

There have been important recent advances in the management of Crohn's disease, including new classes of biological or small molecule therapies, an appreciation that endoscopic mucosal healing results ...

Rune Labs, the leader in precision medicine for Parkinson’s disease (PD), today announced the launch of a clinical program with Parkinson’s Foundation to acc ...

Phil Robertson of "Duck Dynasty" passed away at the age of 79, according to a family statement. He was previously diagnosed with Alzheimer's disease.

Donanemab is only for use in the early stages of Alzheimer’s disease. And for now at least, it comes with a hefty price tag.